EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy

Yuxuan Zhang, Jinjin Wang, Guangchao Qing, Yongchao Wang, Xianlei Li iD, Ting Luo, Yi-Feng Wang, Lu Liu, Yufei Wang, Qiankun Ni, Shuyi Li, Junge Chen und 5 weitere

Proceedings of the National Academy of Sciences · 15.07.2025 · 122 (28)

DOI: 10.1073/pnas.2500589122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 08.07.2025. Verfasst von Yuxuan Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Ch…. Hauptthemen laut MEDLINE: Immunotherapy, T-Lymphocytes, Cell Communication, Biomimetic Materials. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC), Chinese Academy of Sciences (CAS-NSTDA) International Partnership Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has shown tremendous promise in various cancers. However, current strategies, such as immune checkpoint blockade, primarily restore exhausted T cells but provide only transient efficacy, as the rapid clearance of antibodies. Their limited durability is further hindered by persistent T cell-tumor cell interactions that accelerate T cell exhaustion. To prevent T cells from sustained exposure to these interactions, we present a hydrogel-based biomimetic physical barrier (BPB) here to create a “protective zone” for T cells. The BPB temporarily blocks T cell-tumor cell interactions and shields T cells from inactivation and exhaustion, allowing them to accumulate and maintain their functional activity in the tumor microenvironment. After sufficient T cell accumulation, the dismantling of BPB triggered by near-infrared light irradiation-induced gel-sol transition will restore the interaction between T cells and tumor cells. This controlled re-exposure allows the accumulated T cells to attack the tumor cells in a more activated and anti-exhaustion state, maximizing their tumor-killing potential. Moreover, BPB not only enhances immediate tumor regression but also triggers systemic immune activation and durable memory responses, enabling long-term protection against tumor rechallenge and effective control of multifocal tumors. Collectively, our BPB for modulating the T cell-tumor cell interaction has great prospects for advancing cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyT-LymphocytesCell CommunicationBiomimetic MaterialsNeoplasmsMiceAnimalsTumor MicroenvironmentHumansCell Line, TumorBiomimeticsHydrogelsMice, Inbred C57BLFemale

Stichwörter der Autor:innen

T cell and tumor cell interactionT cell exhaustionT cells “protective zone”biomimetic physical barrier (BPB)cancer immunotherapy

Substanzen

Hydrogels

Autor:innen und Institutionen

  • Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, Nation…
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Translational Medicine Center, Key Laboratory of Molecular Target and Clinical Pharmacology, School of Pharmaceutical Sciences and The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
  • State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry and Environmental Science, Hebei U…
  • Department of General Surgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230026, China.

ORCID-Profile: Xianlei Li, Fangzhou Li, Xing-Jie Liang

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)
  • MOST | National Natural Science Foundation of China (NSFC)
  • Chinese Academy of Sciences (CAS-NSTDA) International Partnership Program
  • China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
  • | Natural Science Foundation of Beijing Municipality ()
  • 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality

Zitieren

APA

Zhang, Y., Wang, J., Qing, G., Wang, Y., Li, X., Luo, T., Wang, Y. F., Liu, L., Wang, Y., Ni, Q., Li, S., Chen, J., Li, F., Guo, W., Zhang, J., Gong, N., & Liang, X. J. (2025). Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy. Proceedings of the National Academy of Sciences, 122(28). https://doi.org/10.1073/pnas.2500589122

Vancouver

Zhang Y, Wang J, Qing G, Wang Y, Li X, Luo T, et al. Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy. Proceedings of the National Academy of Sciences. 2025;122(28). doi:10.1073/pnas.2500589122

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuxuan and Wang, Jinjin and Qing, Guangchao and Wang, Yongchao and Li, Xianlei and Luo, Ting and Wang, Yi-Feng and Liu, Lu and Wang, Yufei and Ni, Qiankun and Li, Shuyi and Chen, Junge and Li, Fangzhou and Guo, Weisheng and Zhang, Jinchao and Gong, Ningqiang and Liang, Xing-Jie},
  title = {Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {28},
  doi = {10.1073/pnas.2500589122}
}
Kostenlos starten →